Effect of Aerobic Training on Oxidative Stress Markers in Patients With Parkinson's Disease

Sponsor
Saglik Bilimleri Universitesi (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05511402
Collaborator
Gazi University (Other)
28
1
2
3.5
8

Study Details

Study Description

Brief Summary

Parkinson's disease is a chronic, neurodegenerative disorder characterized with the loss of dopamine-producing neurons. This loss is likely to be related with several environmental and genetic factors. One of the most important factor that is responsible for the initation and progression of the disease is oxidative stress. Exercise training, especially aerobic training, can change the levels of oxidative markers because exercise can lead to decrease oxidative stress in patients with Parkinson's disease. Therefore, this study aims to investigate (1) the effect of aerobic training on total antioxidant status, total oxidant status, glutathione, oxidative glutathione, and zonulin levels, (2) the relationship between the change of motor symptoms and disease severity and the change of total antioxidant status, total oxidant status, glutathione, oxidative glutathione, and zonulin levels.

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Aerobic Training on Total Antioxidant Status, Total Oxidant Status, Glutathione, Oxidative Glutathione and Zonulin Levels in Patients With Parkinson's Disease
Anticipated Study Start Date :
Aug 25, 2022
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Dec 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Aerobic exercise

This group will participate in an aerobic training program (8-week, 3 times weekly, and 30-min each time) and conventional physiotherapy program (8-week, 3 times weekly, and 45-min each time).

Other: Exercise training
People with Parkinson's Disease will be received a supervised physiotherapy and rehabilitation program.

Active Comparator: Conventional physiotherapy

This group will participate in a conventional physiotherapy program (8-week, 3 times weekly, and 45-min each time).

Other: Exercise training
People with Parkinson's Disease will be received a supervised physiotherapy and rehabilitation program.

Outcome Measures

Primary Outcome Measures

  1. Total antioxidant status [10 minutes]

    Total antioxidant status is an important marker of total antioxidant capacity and it indicates an overall measure for the cumulative action of all antioxidants.

  2. Total oxidant status [10 minutes]

    Total oxidant status is an significant marker of total oxidant capacity and it indicates an overall measure for the cumulative action of all oxidants.

  3. Glutathione [10 minutes]

    Glutathione is an important intracellular antioxidant that protects against a variety of different antioxidant species.

  4. Oxidative glutathione [10 minutes]

    Oxidative glutathione generated by glutathione reductase should be provided as decreased glutathione to the site.

  5. Zonulin [10 minutes]

    The levels of zonulin can reflect systemic inflammation and oxidative stress.

Secondary Outcome Measures

  1. Movement Disorders Society Unified Parkinson's Disease Rating Scale [15 minutes]

    The Movement Disorders Society Unified Parkinson's Disease Rating Scale is the most commonly used scale to assess disease severity in Parkinson's Disease. It consists of four parts: (1) non-motor experiences of daily living, (2) motor experiences of daily living, (3) motor examination, and (4) motor complications.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • at least 40years of age

  • diagnosed with Parkinson's Disease

  • Hoehn and Yahr stage of 1 and 3

Exclusion Criteria:
  • any other neurologic disorders,

  • any cardiovascular, orthopedic, vestibular or rheumatic conditions that impact exercise training

  • visual, auditory, and perception problems.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saglik Bilimleri Universitesi Ankara Turkey

Sponsors and Collaborators

  • Saglik Bilimleri Universitesi
  • Gazi University

Investigators

  • Principal Investigator: Ayse Bora Tokcaer, Prof. Dr., Gazi University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fatih Söke, Assistant Professor, Saglik Bilimleri Universitesi
ClinicalTrials.gov Identifier:
NCT05511402
Other Study ID Numbers:
  • 630
First Posted:
Aug 23, 2022
Last Update Posted:
Aug 25, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fatih Söke, Assistant Professor, Saglik Bilimleri Universitesi
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2022